Analgesic nephropathy history and symptoms: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (6 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Analgesic nephropathy}} | {{Analgesic nephropathy}} | ||
{{CMG}} | {{CMG}} {{AE}} {{SHA}} | ||
==Overview== | |||
Common findings in patients with analgesic nephropathy include: [[headache]], upper gastrointestinal disease (such as [[peptic ulcer]]), [[anemia]], [[Urinary tract infection|urinary tract infections]], [[pyuria]] and [[hypertension]]. | |||
==History and Symptoms== | ==History and Symptoms== | ||
History, symptoms and and clinical findings in patients with analgesic nephropathy includes:<ref name="pmid7002190">{{cite journal| author=Nanra RS| title=Clinical and pathological aspects of analgesic nephropathy. | journal=Br J Clin Pharmacol | year= 1980 | volume= 10 Suppl 2 | issue= | pages= 359S-368S | pmid=7002190 | doi=10.1111/j.1365-2125.1980.tb01824.x | pmc=1430193 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7002190 }} </ref><ref name="pmid362034">{{cite journal |author=Nanra RS, Stuart-Taylor J, de Leon AH, White KH |title=Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia |journal=Kidney Int. |volume=13 |issue=1 |pages=79–92 |year=1978 |month=January |pmid=362034 |doi= |url=}}</ref> | |||
| | |||
|- | * [[Headache]] | ||
* Upper gastrointestinal disease (such as [[peptic ulcer]]) | |||
* [[Anemia]] (60%) | |||
| | * [[Mental disorder|Psychiatric disorder]] | ||
| | * [[Urinary tract infection|Urinary tract infections]] (15-60%) | ||
* Sterile [[pyuria]] (95%) | |||
* [[Hypertension]] (15-70%) | |||
* Tubular epithelial celluria | |||
* Microscopic [[hematuria]] (35%) | |||
| | * Significant [[proteinuria]] (greater than 0.3 gr daily) (40%) | ||
* [[Transitional cell carcinoma|Transitional cell tumours]] of the [[urothelium]] (in abuse of [[Analgesic|analgesics]] containing [[phenacetin]]) | |||
| 60 | * Varying degrees of [[Renal insufficiency|renal failure]] (over 85%) | ||
* Clinical [[gout]] (5%) | |||
* [[Acidosis]] | |||
* Passage of papillae | |||
* [[Flanks|Flank]] or [[Abdomen|abdominal]] pain | |||
| | |||
| | |||
| | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 06:23, 8 July 2020
|
Analgesic nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Analgesic nephropathy history and symptoms On the Web |
|
American Roentgen Ray Society Images of Analgesic nephropathy history and symptoms |
|
Risk calculators and risk factors for Analgesic nephropathy history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
Common findings in patients with analgesic nephropathy include: headache, upper gastrointestinal disease (such as peptic ulcer), anemia, urinary tract infections, pyuria and hypertension.
History and Symptoms
History, symptoms and and clinical findings in patients with analgesic nephropathy includes:[1][2]
- Headache
- Upper gastrointestinal disease (such as peptic ulcer)
- Anemia (60%)
- Psychiatric disorder
- Urinary tract infections (15-60%)
- Sterile pyuria (95%)
- Hypertension (15-70%)
- Tubular epithelial celluria
- Microscopic hematuria (35%)
- Significant proteinuria (greater than 0.3 gr daily) (40%)
- Transitional cell tumours of the urothelium (in abuse of analgesics containing phenacetin)
- Varying degrees of renal failure (over 85%)
- Clinical gout (5%)
- Acidosis
- Passage of papillae
- Flank or abdominal pain
References
- ↑ Nanra RS (1980). "Clinical and pathological aspects of analgesic nephropathy". Br J Clin Pharmacol. 10 Suppl 2: 359S–368S. doi:10.1111/j.1365-2125.1980.tb01824.x. PMC 1430193. PMID 7002190.
- ↑ Nanra RS, Stuart-Taylor J, de Leon AH, White KH (1978). "Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia". Kidney Int. 13 (1): 79–92. PMID 362034. Unknown parameter
|month=ignored (help)